enVVeno Medical (NVNO) Income from Continuing Operations (2017 - 2026)
enVVeno Medical (NVNO) posted quarterly Income from Continuing Operations of 3787000.0 for Q2 2026, up 44.75% year-over-year from 2616278.4 in Q2 2025, and up 6.26% quarter-over-quarter from 4040000.0 in Q1 2026.
enVVeno Medical (NVNO) Income from Continuing Operations (2017 - 2026) Analysis & Trends
enVVeno Medical's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 3787000.0 for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 44.75% year-over-year to 3787000.0; the TTM figure through Jun 2026 stood at 16844000.0 (up 31.27% YoY), while the FY2025 annual figure was 20933000.0, up 12.13% from the prior year.
- Income from Continuing Operations for Q2 2026 stood at 3787000.0, up from 4040000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 3787000.0 in Q2 2026, with the low at 7670000.0 in Q4 2023.
- The 5-year median for Income from Continuing Operations is 5760000.0 (2024), against an average of 5772111.11.
- The sharpest annual moves came in 2022 and 2026: Income from Continuing Operations tumbled 146.9% in 2022, then surged 44.75% in 2026.
- enVVeno Medical's Income from Continuing Operations stood at 6714000.0 in 2022, then decreased by 14.24% to 7670000.0 in 2023, then increased by 10.8% to 6842000.0 in 2024, then surged by 37.02% to 4309000.0 in 2025, then climbed by 12.11% to 3787000.0 in 2026.
- Business Quant data shows NVNO's Income from Continuing Operations at 3787000.0 in Q2 2026, 4040000.0 in Q1 2026, and 4309000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | enVVeno Medical | 7.12 Mn | 7.12 Mn | - | -3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.79 Mn |
| Mar 31, 2026 | -4.04 Mn |
| Dec 31, 2025 | -3.94 Mn |
| Sep 30, 2025 | -4.71 Mn |
| Jun 30, 2025 | -6.85 Mn |
| Mar 31, 2025 | -4.74 Mn |
| Dec 31, 2024 | -6.84 Mn |
| Sep 30, 2024 | -6.08 Mn |
| Jun 30, 2024 | -5.38 Mn |
| Mar 31, 2024 | -5.44 Mn |
| Dec 31, 2023 | -7.67 Mn |
| Sep 30, 2023 | -5.31 Mn |
| Jun 30, 2023 | -6.81 Mn |
| Mar 31, 2023 | -6.80 Mn |
| Dec 31, 2022 | -6.71 Mn |
| Sep 30, 2022 | -6.10 Mn |
| Jun 30, 2022 | -6.99 Mn |
| Mar 31, 2022 | -5.34 Mn |
| Dec 31, 2021 | -9.33 Mn |
| Sep 30, 2021 | -3.06 Mn |